Four things to know about the meeting:
- The CDC committee’s role is to decide who should get boosters of Pfizer’s COVID-19 vaccine and when. The FDA’s vaccine advisory committee voted Sept. 17 to authorize a booster dose of Pfizer’s vaccine in people ages 65 and older and those at high risk of severe disease. The CDC committee is to decide who belongs in the high-risk category, according to The New York Times.
- Similar to the way the FDA vaccine panel’s decisions are not final until accepted by the FDA, the CDC advisory committee’s recommendations for who gets a booster shot must be accepted by CDC Director Rochelle Walensky, MD.
- The committee’s decision may not come until late afternoon Sept. 23, the Times reported. The FDA may make a formal decision on authorizing a booster of Pfizer’s shot before the CDC committee makes its recommendation, according to CNBC.
- The CDC advisory committee is independent of the FDA and hasn’t always aligned with the FDA’s decision on who should get a certain vaccine, USA Today noted.
Find the CDC committee’s meeting agenda here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
